Antisense oligonucleotides against hepatitis b viral...

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/04 (2006.01) A61K 31/70 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2196070

Antisense oligonucleotides that hybridize to segments of the preS1, S, C, and epsilon regions of the hepatitis B virus (HBV) RNA pregenome inhibit replication of the virus. The figure illustrates the relative positions of antisense oligonucleotides targeted against the HBV S gene. Pharmaceutical compositions which contain these oligonucleotides as the active ingredients are effective against HBV infection.

Des oligonucléotides antisens s'hybridant à des segments des régions preS1, S, C et epsilon du prégénome de l'ARN du virus de l'hépatite B (HBV) inhibent la réplication de ce virus. La figure illustre les positions relatives d'oligonucléotides antisens ciblés contre le gène S de HBV. Des compositions pharmaceutiques contenant ces oligonucléotides en tant qu'ingrédients actifs sont efficaces contre l'infection par HBV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense oligonucleotides against hepatitis b viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotides against hepatitis b viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides against hepatitis b viral... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436519

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.